Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).

Nodarse-Cuní, Hugo

Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report). [electronic resource] - The Journal of laryngology and otology Sep 2004 - 681-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0022-2151

10.1258/0022215042244741 doi


Adolescent
Adult
Aged
Antineoplastic Agents--adverse effects
Antiviral Agents--adverse effects
Chemotherapy, Adjuvant
Child
Child, Preschool
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Infant
Interferon alpha-2
Interferon-alpha--adverse effects
Laryngeal Neoplasms--drug therapy
Male
Middle Aged
Papilloma--drug therapy
Recombinant Proteins--therapeutic use
Recurrence
Respiratory Tract Neoplasms--drug therapy
Treatment Outcome